Cargando…

A Review on Remdesivir: A Possible Promising Agent for the Treatment of COVID-19

The novel coronavirus 2019 (2019-nCoV), formally named severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), is a novel human infectious coronavirus. The disease caused by SARS-CoV-2 is named COVID-19. Development and manufacturing of specific therapeutics and vaccines to treat COVID-19 are...

Descripción completa

Detalles Bibliográficos
Autores principales:	Hashemian, Seyed MohammadReza, Farhadi, Tayebeh, Velayati, Ali Akbar
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove 2020
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7425093/ https://www.ncbi.nlm.nih.gov/pubmed/32821086 http://dx.doi.org/10.2147/DDDT.S261154

Ejemplares similares

A review on modafinil: the characteristics, function, and use in critical care
por: Hashemian, Seyed MohammadReza, et al.
Publicado: (2020)

Computer-aided design of amino acid-based therapeutics: a review
por: Farhadi, Tayebeh, et al.
Publicado: (2018)

Virtual screening for potential inhibitors of β(1,3)-D-glucan synthase as drug candidates against fungal cell wall
por: Farhadi, Zinat, et al.
Publicado: (2020)

Comment on: Safety and efficacy of Favipiravir in moderate to severe SARS-CoV-2 pneumonia
por: Hashemian, Seyed MohammadReza, et al.
Publicado: (2022)

Fosfomycin: the characteristics, activity, and use in critical care
por: Hashemian, Seyed Mohammad Reza, et al.
Publicado: (2019)

Linezolid: a review of its properties, function, and use in critical care
por: Hashemian, Seyed Mohammad Reza, et al.
Publicado: (2018)

Non-coding RNAs and Exosomes: Their Role in the Pathogenesis of Sepsis
por: Hashemian, Seyed MohammadReza, et al.
Publicado: (2020)

Remdesivir as a possible therapeutic option for the COVID-19
por: Al-Tawfiq, Jaffar A., et al.
Publicado: (2020)

Continues renal replacement therapy (CRRT) with disposable hemoperfusion cartridge: A promising option for severe COVID-19
por: Dastan, Farzaneh, et al.
Publicado: (2020)

Iran's Approach to COVID-19: Evolving Treatment Protocols and Ongoing Clinical Trials
por: Rahmanzade, Ramin, et al.
Publicado: (2020)

Etiology of Respiratory Complications among Iranian HIV Infected Patients
por: Marjani, Majid, et al.
Publicado: (2019)

Indian perspective of remdesivir: A promising COVID-19 drug
por: Singh, Devendra, et al.
Publicado: (2020)

Prevalence of Oseltamivir-Resistant 2009 H1N1 Influenza Virus among Patients with Pandemic 2009 H1N1 Influenza infection in NRITLD, Tehran, Iran
por: Moradi, Ahmadreza, et al.
Publicado: (2011)

New Perspectives on Antimicrobial Agents: Remdesivir Treatment for COVID-19
por: Aleissa, Muneerah M., et al.
Publicado: (2020)

Clinical Features and Outcomes of ICU Patients with COVID-19 Infection in Tehran, Iran: a Single-Centered Retrospective Cohort Study
por: Vahedi, Arshia, et al.
Publicado: (2020)

A Fourteen-day Experience with Coronavirus Disease 2019 (COVID-19) Induced Acute Respiratory Distress Syndrome (ARDS): An Iranian Treatment Protocol
por: Jamaati, Hamidreza, et al.
Publicado: (2020)

The efficacy of remdesivir in coronavirus disease 2019 (COVID-19): a systematic review
por: Roshanshad, Amirhossein, et al.
Publicado: (2020)

Remdesivir for coronavirus 2019 (COVID-19): More promising but still unproven
por: Shih, Richard D., et al.
Publicado: (2020)

Factors associated with death or intensive care unit admission due to pandemic 2009 influenza A (H1N1) infection
por: Tabarsi, Payam, et al.
Publicado: (2011)

H1N1 Influenza Patient Saved by Extracorporeal Membrane Oxygenation: First Report from Iran
por: Jahangirifard, Alireza, et al.
Publicado: (2016)

A promising antiviral candidate drug for the COVID-19 pandemic: A mini-review of remdesivir
por: Liang, Chengyuan, et al.
Publicado: (2020)

The place for remdesivir in COVID-19 treatment
por: Young, Barnaby, et al.
Publicado: (2021)

Combination therapy of IFNβ1 with lopinavir–ritonavir, increases oxygenation, survival and discharging of sever COVID-19 infected inpatients
por: Baghaei, Parvaneh, et al.
Publicado: (2021)

A Mini Review on Discovery and Synthesis of Remdesivir as an Effective and Promising Drug against COVID-19
por: Zarenezhad, E., et al.
Publicado: (2021)

Remdesivir and COVID-19
por: Ferrara, Francesco, et al.
Publicado: (2020)

Remdesivir for COVID-19
Publicado: (2020)

Remdesivir and COVID-19
por: Glaus, Matthew J, et al.
Publicado: (2020)

Remdesivir and COVID-19
por: Wang, Lei-Yun, et al.
Publicado: (2020)

Remdesivir and COVID-19
por: Dennis, Alicia
Publicado: (2020)

Remdesivir and COVID-19
por: Edwards, Jessie K, et al.
Publicado: (2020)

Study Protocol on Antimicrobial Stewardship in a Tertiary Respiratory Referral Hospital
por: Jamaati, Hamidreza, et al.
Publicado: (2018)

Available Evidence and Ongoing Clinical Trials of Remdesivir: Could It Be a Promising Therapeutic Option for COVID-19?
por: Sisay, Mekonnen
Publicado: (2020)

Pulmonary administration of remdesivir in the treatment of COVID-19
por: Rasmussen, Henrik Berg, et al.
Publicado: (2020)

Remdesivir for the Treatment of Covid-19 — Final Report
por: Beigel, John H., et al.
Publicado: (2020)

Remdesivir for the treatment of COVID-19: author's response
por: Lee, Todd C., et al.
Publicado: (2023)

Trisomy 21 as a Risk Factor for Severe Illness in COVID-19: Report of two Cases
por: Babamahmoodi, Abdolreza, et al.
Publicado: (2020)

Remdesivir for pregnancy: A systematic review of antiviral therapy for COVID-19
por: Budi, David Setyo, et al.
Publicado: (2022)

COVID-19 in Iran: A model for Crisis Management and Current Experience
por: Jamaati, Hamidreza, et al.
Publicado: (2020)

Remdesivir: A Review in COVID-19
por: Blair, Hannah A.
Publicado: (2023)

Remdesivir for patients with COVID-19
por: Wu, Peter E., et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_rpdfqbpvpe13rqv5qtctja5vpm